Pamela Disanto was diagnosed with keratoconus decades ago, and later went on to receive a corneal transplant – the only long-term treatment option available at the time. Today, Pamela has three sons, two of whom were diagnosed with progressive keratoconus in their early 20s. Both of her sons were treated with FDA-approved corneal cross-linking, and Pamela now uses her experience to educate other families about the hereditary nature of the disease and the available treatment options.

MA-00000A